A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma.

A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma.

Item
http://www.wikidata.org/entity/Q33379208
Cancer therapies utilizing the camptothecins: a review of the in vivo literatureActively targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritisSingle-antibody, targeted nanoparticle delivery of camptothecin.Clinical developments in nanotechnology for cancer therapy.Therapeutic nanoparticles in clinics and under clinical evaluation.Etirinotecan pegol: development of a novel conjugated topoisomerase I inhibitor.Effects of pharmaceutical PEGylation on drug metabolism and its clinical concerns.PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system.Poly(2-ethyl-2-oxazoline) as alternative for the stealth polymer poly(ethylene glycol): comparison of in vitro cytotoxicity and hemocompatibility.Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and ApplicationsCamptothecin-based nanodrug delivery systems.Camptothecin and thiocamptothecin: the role of sulfur in shifting the hydrolysis equilibrium towards the closed lactone form.Water Soluble Polymers for Pharmaceutical Applications
P2860

A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma.

Item
http://www.wikidata.org/entity/Q33379208
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A phase II study of pegylated- ...... ageal junction adenocarcinoma.
@ast
A phase II study of pegylated- ...... ageal junction adenocarcinoma.
@en
type
label
A phase II study of pegylated- ...... ageal junction adenocarcinoma.
@ast
A phase II study of pegylated- ...... ageal junction adenocarcinoma.
@en
prefLabel
A phase II study of pegylated- ...... ageal junction adenocarcinoma.
@ast
A phase II study of pegylated- ...... ageal junction adenocarcinoma.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
A phase II study of pegylated- ...... ageal junction adenocarcinoma.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921